FIELD: biotechnology.
SUBSTANCE: described is a recombinant vector plasmid for transferring and delivering a heterogeneous polynucleotide sequence into a mammalian cell, comprising: an adeno-associated virus (AAV) vector genome containing a heterologous polynucleotide sequence and an expression control sequence, which triggers a transcription of the heterologous polynucleotide sequence; and main sequence, containing a first inert polynucleotide filler sequence or a spacer polynucleotide sequence, wherein said heterologous polynucleotide sequence in length is less than 4.7 Kb and is located between two sequences of inverted end repeat (ITR) adenoassociated virus (AAV), wherein said first inert polynucleotide filler sequence or spacer polynucleotide sequence is located outside the ITR AAV and has length of 4.5–10 Kb or 6–8 Kb and where length of said main sequence is at least 7.0 Kb. Said heterologous polynucleotide codes a protein which provides therapeutic benefit, or encodes an inhibitory nucleic acid, which reduces or inhibits expression of an undesired or defective gene.
EFFECT: invention reduces impurities of residual plasmid DNA.
42 cl, 6 dwg, 3 ex
Title |
Year |
Author |
Number |
VARIANT AAV, COMPOSITIONS AND METHODS, IN WHICH IT IS USED, AS WELL AS METHODS OF ITS APPLICATION FOR TRANSFER OF GENES INTO CELLS, ORGANS AND TISSUES |
2014 |
- Khaj Ketrin A.
- Yazisioglu Mustafa N.
- Angela Khaver
|
RU2697444C2 |
AAV VECTOR AND NEUTRALIZING ANTIBODIES AGAINST AAV (ADENO-ASSOCIATED VIRUS) ANALYSIS |
2014 |
- Khaj Ketrin A.
- Mingozzi Federiko
- Chen Ifyn
|
RU2705249C2 |
MODIFIED FACTOR IX, AS WELL AS COMPOSITIONS, METHODS AND OPTIONS FOR THE USE OF GENE TRANSFER INTO CELLS, ORGANS AND TISSUE |
2016 |
- Khaj Ketrin A.
- Angela Khaver
|
RU2811445C2 |
RNAi AGENT OPTION |
2018 |
- O'Riordan, Catherine R.
- Palermo, Adam
- Richards, Brenda
- Stanek, Lisa M.
|
RU2789647C2 |
SCALABLE METHODS FOR OBTAINING RECOMBINANT VECTOR BASED ON ADENO-ASSOCIATED VIRUS (AAV) IN SYSTEM OF SERUM-FREE SUSPENSION CELL CULTURE, SUITABLE FOR CLINICAL USE |
2016 |
- Qu, Guang
- Lu, Lin
- Wright, John Fraser
|
RU2766583C2 |
MODIFIED ADENO-ASSOCIATED VIRUS VECTOR COMPOSITIONS |
2013 |
- Devidson, Beverli, L.
- Shchil, Mariya
- Budro, Rajan
- Mas Montejs, Alekhandro
|
RU2679843C2 |
PROMOTER COMPOSITIONS |
2014 |
- Dejvidson Beverli L.
- Rodrigez Edgardo
- Mas Montejs Alekhandro
|
RU2742435C2 |
AMPLIFIER AGENTS TO INCREASE CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION |
2018 |
- Qu, Guang
- Lu, Lin
- Josue-Almqvist, Jesusa
- Wright, John Fraser
|
RU2802520C2 |
COMPLETELY SCALABLE METHOD FOR PRODUCING rAAV BASED ON COLUMNS |
2017 |
- Qu, Guang
- Oh, Younghoon
- Lu, Lin
- Wright, John Fraser
|
RU2754467C2 |
COMPOSITIONS AND METHODS OF TREATING AND PREVENTING MACULAR DEGENERATION |
2015 |
|
RU2703145C2 |